Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
M&A / Property Routine +

Gstaad Capital closes QT, changes name to Illumisoft

Shell company completes reverse takeover with germicidal UV product

Executive Summary
  • Illumisoft Lighting Corp., formerly Gstaad Capital Corp., has completed a qualifying transaction (QT) via amalgamation with Claranova Technologies Inc.
  • The company is now listed on the TSX Venture Exchange under ticker symbol UVC, trading anticipated to begin April 23, 2026.
  • A share consolidation occurred at a ratio of 0.2 post-consolidated shares for every pre-consolidation common share.
  • Claranova Technologies Inc. is now a wholly owned subsidiary; Illumisoft acquired all of Claranova's assets.
  • Subscription receipts previously issued at $0.30 (gross proceeds $6,441,975) were exchanged for post-consolidation shares.
  • A debenture was issued in exchange for Claranova’s outstanding debt ($333,333 principal), repayable on May 4, 2026.
  • New equity incentives include 3,540,000 stock options and 425,390 share purchase warrants, all exercisable at $0.30 per post-consolidation common share.
  • Auditor changed from Crowe MacKay LLP to Kenway Mack Slusarchuk Stewart LLP.
Material Impact
  • The completion of the QT is a standard milestone for shell companies that have previously announced their intent and raised capital (subscription receipts were "previously issued").
  • The news confirms the transition from a shell entity to an operating company with a Health Canada-registered product, which validates the business model but does not introduce new unexpected upside.
  • The immediate debt maturity of $333,333 due May 4, 2026 (13 days post-news) creates significant near-term liquidity pressure for a newly listed entity.
  • Dilution is substantial with over 3.9 million warrants/options issued at the current strike price ($0.30), capping immediate upside if exercised or sold by insiders.
  • The rating reflects that while the listing and capital raise are positive, they were largely anticipated given the prior issuance of subscription receipts; thus, it is routine rather than a game changer.
UVC · Price
Company Overview
  • Company: Illumisoft Lighting Corp. (formerly Gstaad Capital Corp.).
  • Flagship Project: Health Canada-registered upper-room germicidal ultraviolet air disinfection product.
  • Business Model: Commercial lighting business combined with UV air disinfection technology.
  • Development Status: Product preparing to enter active commercial use; assets acquired via QT from Claranova Technologies Inc.
Read the original news release →

More from Illumisoft Lighting Corp